Merck & Company Inc (MRK)

NYSE
Currency in USD
83.29
+0.28(+0.34%)
Closed
Pre Market
83.49+0.20(+0.24%)

MRK Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa41,51848,70459,28360,11564,168
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+6.13%+17.31%+21.72%+1.4%+6.74%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa11,99013,46617,20615,91512,289
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa29,52835,23842,07744,20051,879
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+5.23%+19.34%+19.41%+5.05%+17.37%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa71.12%72.35%70.98%73.53%80.85%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa19,13321,34521,58728,22629,114
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa+9.81%+11.56%+1.13%+30.75%+3.15%
aa.aaaa.aaaa.aaaa.aaaa.aa10,56411,94211,91818,34217,865
aa.aaaa.aaaa.aaaa.aaaa.aa8,5699,4039,6699,88411,249
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa10,39513,89320,49015,97422,765
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-2.28%+33.65%+47.48%-22.04%+42.51%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa25.04%28.53%34.56%26.57%35.48%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-713-770-805-781-856
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-15.19%-7.99%-4.55%+2.98%-9.6%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-831-806-962-1,146-1,271
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa11836157365415
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-74-41444501,420
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa9,60813,08220,12915,24323,329
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-90-275-1,600-1,352-2,519
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5,86313,87916,4441,88919,936
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-18.24%+136.72%+18.48%-88.51%+955.37%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa14.12%28.5%27.74%3.14%31.07%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,3401,5211,9181,5122,803
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa7,07113,06214,52637717,133
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-4-13-7-12-16
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,06713,04914,51936517,117
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-28.2%+84.65%+11.27%-97.49%+4,589.59%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa17.02%26.79%24.49%0.61%26.68%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa4,51912,34514,51936517,117
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.794.885.730.146.74
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-19.48%+173.18%+17.52%-97.49%+4,582.23%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.784.865.710.146.74
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-19.46%+173.03%+17.49%-97.55%+4,711.66%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa2,5302,5302,5322,5372,541
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa2,5412,5382,5422,5472,541
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa2.442.62.762.923.08
Dividend Per Share Growth
aa.aaaa.aaaa.aa